Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-masked, Vehicle-controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children

NCT03918915 is registered in ClinicalTrials.gov with Sydnexis, Inc. as lead sponsor.

NCT NCT03918915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03918915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-masked, Vehicle-controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children
Lead sponsor
Sydnexis, Inc.
Phase
Phase 3
Overall status
Completed
Start date
April 24, 2019
Completion date
May 1, 2025
Enrollment
852 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

near sightedness, near-sightedness, nearsightedness